JI

JIN YANG PHARMACEUTICAL. CO., LTD

Develops and manufactures prescription drugs for cancer and metabolic disorders.

007370 | KO

Overview

Corporate Details

ISIN(s):
KR7007370000
LEI:
Country:
South Korea
Address:
서울특별시 서초구 효령로 231, 서울특별시

Description

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
주주총회소집공고
Korean 48.0 KB
2025-09-17 00:00
의결권대리행사권유참고서류
Korean 46.2 KB
2025-08-18 00:00
주주총회소집결의 (임시주주총회)
Korean 12.1 KB
2025-08-18 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 1.0 MB
2025-07-09 00:00
주식등의대량보유상황보고서(일반)
Korean 121.3 KB
2025-07-08 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
신탁계약해지결과보고서
Korean 30.6 KB
2025-07-08 00:00
신탁계약해지결과보고서
Korean 25.2 KB
2025-07-08 00:00
신탁계약해지결과보고서
Korean 31.3 KB
2025-07-03 00:00
주요사항보고서(자기주식처분결정)
Korean 30.2 KB
2025-07-03 00:00
자기주식처분결과보고서
Korean 18.7 KB
2025-07-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB

Automate Your Workflow. Get a real-time feed of all JIN YANG PHARMACEUTICAL. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JIN YANG PHARMACEUTICAL. CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JIN YANG PHARMACEUTICAL. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.